Although NRF2 is known to promote PanIN formation and sustain PDA, we found that active NRF2 levels are significantly lower in human IPMN compared with PanIN and PDA. This evidence concerns the gene NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm.